AI Assistant
Blog
Pricing
Log In
Sign Up
Ocrelizumab is dampening the harm inflammation in patients with multiple sclerosis with little impact on protective immunity
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
